Anales espanoles de pediatria
Recommendations for inhaled nitric oxide treatment in the newborn diseases
Abstract
The recommendations in this document highlight current indications for inhaled nitric oxide (iNO) treatment in the newborn by clearly differentiating between those that are supported by scientific evidence and those for which evidence is still lacking. However, the use of this treatment in preterm infants and in those with congenital heart disease has not yet been scientifically approved. We discuss the methodology, dosage and adverse effects of iNO administration, as well as the reasons for its ineffectiveness.
Source and rights
Published by Anales espanoles de pediatria, 2001. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2001
- Applies to
- 🇪🇸 Spain
- Scope
- National
- Journal
- Anales espanoles de pediatria
- PubMed
- 11676901
- Added to Prognia
- 25 July 2026
More in paediatrics
- Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Focused Guidelines on Acute Heart Failure in ChildrenCanadian Cardiovascular Society/Canadian Pediatric Cardiology Association · 2026
- UK consensus guidelines for multidisciplinary care of children and young people with achondroplasia: a modified Delphi processThe UK Achondroplasia Network · 2026
